The Immune Assessment of PD-1 Antibody Therapy in Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQuanli Gao
About this trial
This retrospective study will leverage previous immune function monitoring results in conjunction with clinical case data at this medical center.
Eligibility criteria
Qualifiers
Age ≥18 years.
Pathologically confirmed malignant tumors.
Complete medical records.
Assessable immune function test data.
Disqualifiers
Age <18 years.
No confirmed tumor pathology.
Untraceable medical records.
Non-assessable immune function tests.
Trial design
Treatments tested in this trial
- PD-1 Inhibitors
Treatment groups
3,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Quanli Gao
Lead sponsor
Henan Cancer Hospital
Sponsor institution
Source ClinicalTrials.gov